Friedreich's ataxia

GPTKB entity

Statements (51)
Predicate Object
gptkbp:instanceOf neurodegenerative disease
genetic disorder
gptkbp:abbreviation gptkb:FRDA
gptkbp:affects gptkb:nervous_system
cardiovascular system
musculoskeletal system
gptkbp:causedBy mutation in FXN gene
gptkbp:complication gptkb:arrhythmia
gptkb:diabetes
heart failure
gptkbp:containsGene gptkb:FXN
gptkbp:diagnosedBy neurological examination
MRI
genetic testing
electromyography
echocardiogram
gptkbp:firstDescribed gptkb:Nikolaus_Friedreich
1863
gptkbp:frequency 1 in 40,000 to 50,000 people
gptkbp:hasCarrierFrequency 1 in 90 to 100 people
gptkbp:hasGeneticMutationType gptkb:GAA_trinucleotide_repeat_expansion
gptkbp:hasInheritanceRisk 25% if both parents are carriers
gptkbp:hasOrphanetID ORPHA95
gptkbp:hasProteinDeficiency gptkb:frataxin
gptkbp:hasResearchCenter gene therapy
iron chelation therapy
antioxidant therapy
https://www.w3.org/2000/01/rdf-schema#label Friedreich's ataxia
gptkbp:ICD-10_code G11.1
gptkbp:inheritance autosomal recessive
gptkbp:MeSH_ID D001285
gptkbp:OMIM 229300
gptkbp:onset childhood
adolescence
gptkbp:prevalence rare
gptkbp:prognosis progressive
reduced life expectancy
wheelchair dependence within 10-20 years of onset
gptkbp:symptom gptkb:diabetes_mellitus
muscle weakness
scoliosis
ataxia
cardiomyopathy
loss of coordination
dysarthria
gptkbp:treatment supportive care
physical therapy
speech therapy
cardiac management
gptkbp:bfsParent gptkb:Ataxia_with_vitamin_E_deficiency
gptkbp:bfsLayer 5